Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neurontin for chronic cough
ACTRN12608000248369Phase 3Completed
- Sponsor
- Hunter New England Local Health District
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic cough comparing Neurontin with Placebo (2 arms). Primary endpoint: Improvement in cough quality of life at week 16. Started Oct 2008; status: completed.
02
Drugs
gabapentin
03
Conditions
chronic cough
Beyond the preview
Go deeper on ACTRN12608000248369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000248369.